KLK3 and posterior cortical atrophy: Due to the pronounced heterogeneity and complex nature of CRPC, it would be most beneficial if existing panels of biomarkers, including PSA and maybe other kallikreins, could be combined with additional, novel biomarkers that are more specific for PCa and the mechanisms of disease progression.